HQ Function

Serves as a major manufacturing and development site for small molecule APIs and intermediates. It is a crucial part of Ajinomoto Bio-Pharma Services' global CDMO network, focusing on process development, cGMP manufacturing, and high-potency compounds.

Notable Features:

Advanced cGMP manufacturing suites, high containment facilities for potent compounds, extensive R&D laboratories, and pilot plant capabilities.

Work Culture:

The work culture emphasizes precision, quality, safety, and scientific innovation, typical of a pharmaceutical CDMO. There is a strong focus on collaboration, continuous improvement, and meeting stringent regulatory standards within a global operational framework.

HQ Significance:

This site represents Ajinomoto's long-standing expertise in chemical synthesis and pharmaceutical ingredient manufacturing, forming a cornerstone of their European CDMO operations and a vital link in their global supply chain.

Values Reflected in HQ: The facility and its operations reflect Ajinomoto's core values of quality, reliability, innovation, and a commitment to contributing to global health through advanced pharmaceutical manufacturing.

Location:

Ajinomoto OmniChem, as an integral part of Ajinomoto Bio-Pharma Services, contributes to a robust global presence. Ajinomoto Bio-Pharma Services operates key manufacturing and development sites in Belgium (Wetteren), the United States (San Diego, CA; Glen Allen, VA), India (Visakhapatnam), and Japan. This international network supports global pharmaceutical and biotech companies by offering a wide range of services, including API development and manufacturing (small molecules, oligonucleotides, peptides), aseptic fill/finish services, plasmid DNA production, and specialized technologies like AJIPHASE® for peptide and oligonucleotide synthesis and Corynex® for protein expression.

Street Address:

Cooppallaan 91

City:

Wetteren

State/Province:

East Flanders

Country:

Belgium